TWIST1 and breast carcinoma: However, since integrin α5 and integrin β1 served as important mesenchymal marker to regulate EMT during breast cancer (Nam et al. 2015), the effect of TFPI2-mediated TWIST1 on regulation of integrin β1 also needs to be further investigated.